XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.3
SEGMENT REPORTING (Tables)
9 Months Ended
Sep. 30, 2024
Segment Reporting [Abstract]  
SCHEDULE OF SEGMENTS

The following table presents certain information regarding the Company’s segments as of and for the three months ended September 30, 2024 and 2023 (in thousands):

 

2024

 

   CVD Equipment   SDC   CVD Materials   Eliminations   Corporate   Consolidated 
 Assets  $27,270   $3,805   $836   $(65)  $-   $31,846 
                               
Revenue  $5,681   $2,005   $661   $(153)  $-   $8,194 
Operating (loss) income   *(736)   538    **1,104    18    (847)   77 
Pretax (loss) income   *(741)   538    **1,104    18    (711)   208 
Depreciation and amortization  $157   $12   $-   $-   $-   $169 
Purchase of property, plant & equipment  $30   $7   $-   $-   $-   $37 

 

2023

 

   CVD Equipment   SDC   CVD Materials   Eliminations   Corporate   Consolidated 
 Assets  $32,915   $4,237   $177   $(102)  $-   $37,227 
                               
Revenue  $4,795   $1,572   $90   $(223)  $-   $6,234 
Operating (loss) income   (323)   436    (35)   (76)   (992)   (990)
Pretax (loss) income   (262)   434    (31)   (76)   (818)   (753)
Depreciation and amortization  $137   $12   $4   $-   $-   $153 
Purchase of property, plant & equipment  $83   $-   $-   $-   $-   $83 

 

*Includes a $1.0 million non-cash charge to reduce certain inventory to net realizable value – see Note 5.

 

**Includes gain on sale of equipment of $0.6 million related to MesoScribe – see Note 11.

 

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

NOTE 10: SEGMENT REPORTING (continued)

 

The following table presents certain information regarding the Company’s segments as of and for the nine months ended September 30, 2024 and 2023 (in thousands):

 

2024

 

   CVD Equipment   SDC   CVD Materials   Eliminations   Corporate   Consolidated 
                         
Revenue  $12,737   $6,252   $775   $(302)  $-   $19,462 
Operating (loss) income   *(2,884)   1,884    **1,034    28    (2,513)   (2,451)
Pretax (loss) Income   *(2,894)   1,884    **1,034    28    (2,075)   (2,025)
Depreciation and amortization  $441   $35   $-   $-   $-   $476 
Purchase of property, plant & equipment  $209   $10   $-   $-   $-   $219 

 

2023

 

   CVD Equipment   SDC   CVD Materials   Eliminations   Corporate   Consolidated 
                         
Revenue  $13,774   $5,679   $1,009   $(554)  $-   $19,998 
Operating (loss) income   (581)   1,430    ***(178)   (104)   (2,977)   (2,410)
Pretax (loss) Income   (518)   1,430    ***(126)   (104)   (2,577)   (1,895)
Depreciation and amortization  $404   $36   $105   $-   $-   $545 
Purchase of property, plant & equipment  $298   $10   $-   $-   $-   $308 

 

*Includes a $1.0 million non-cash charge to reduce certain inventory to net realizable value – see Note 5.

 

**Includes gain on sale of equipment of $0.6 million related to MesoScribe – see Note 11.

 

***Includes loss on sale of Tantaline of $0.2 million and impairment charge related to MesoScribe fixed assets of $0.1 million – see Note 11.